This is a $16,071.75 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Prolia 60 mg/ml syringes, a specialty medication used for treating certain medical conditions. The contract has an ultimate completion date of March 14, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This $1,420.25 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of PROLIA 60 MG/ML SYRINGEML. The order has a period of performance ending on July 30, 2024. Amerisourcebergen, as a major pharmaceutical distributor, leverages its extensive supply chain to provide a wide range of medical commodities to various government agencies through multiple Indefinite Delivery Contracts (IDCs), including a $999,999,999 IDC with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROLIA 60 MG/ML SYRINGEML. The contract has a firm fixed price of $13,176.99 and a period of performance through August 1, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for delivering a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,975.84, is for the delivery of PROLIA 60 MG/ML SYRINGEML, a prescription medication. The contract is not set aside and is a firm fixed-price, delivery order. It has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,714.50, is for the delivery of PROLIA 60 MG/ML SYRINGEML, a prescription medication, to support federal medical requirements. The contract has an ultimate completion date of June 5, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order worth $34,232.81 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Firm Fixed Price contract, which has an ultimate completion date of December 20, 2024, is for the delivery of 4566771042 - PROLIA 60 MG/ML SYRINGEML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,834.36, is for the delivery of PROLIA 60 MG/ML SYRINGEML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of November 8, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a $15,654.22 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Prolia 60 mg/ml syringes. The order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 between Amerisourcebergen and the DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROLIA 60 MG/ML SYRINGE, a pharmaceutical product, with a ceiling value of $31,265.59 and a period of performance through May 19, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,264.23, is for the delivery of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating open competition....